Revision to the Notification of Stolen Eli Lilly and Company Products- 23nd March, 2010

FDA posts press releases and other notices from firms as a service to consumers, the media, and other interested parties

As reported on FDA and Lilly.com websites on March 18, 2010, Eli Lilly and Company is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly’s United States distribution centers located in Enfield, Connecticut, on Sunday, March 14, 2010.  During a comprehensive follow-up inventory assessment related to the theft, two (2) additional lots were confirmed to be stolen. These lots are:

Zyprexa TAB 20MG X30BOTL AM, Lot number A677963A,

 Cymbalta CAP20MG X 60 BOTL AM, lot number A669975A.

A revised list of products stolen from the facility can be found in a table at the bottom of this notice. The two additional lot numbers are highlighted in yellow in the table. 

Product from all these lot numbers was previously distributed by Lilly within the United States, Puerto Rico and its territories. To assist the FDA and the law enforcement agencies in their investigation, Lilly has stopped distributing all of those products with the affected lot numbers.

These medicines require a prescription for purchase.  Practitioners, pharmacies, and consumers are advised to purchase Lilly products only from well-established, trusted and reputable sources and to be aware that an unusually low price is often an indication that a product has been stolen.  Additionally, all pharmaceutical products should always be checked for signs of tampering or damage prior to purchase and/or use.  Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way. 

Anyone who has information regarding this incident or has received suspicious or unsolicited offers for the affected Eli Lilly products after the date of the theft is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989 or by visiting the OCI Web Site (http://www.fda.gov/OCI).

For medical or other related inquiries about this matter, contact Lilly at 1-800-LILLYRX (1-800-545-5979)

Impacted Products